Expression of PD-ECGF/TP in Lung Cancer Cell Lines
Author Information
Author(s): N.-E. Heldin, K. Usuki, J. Bergh, B. Westermark, C.-H. Heldin
Primary Institution: University Hospital, Uppsala, Sweden; Ludwig Institute for Cancer Research, Uppsala, Sweden
Hypothesis
The study investigates the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in different human lung carcinoma cell lines.
Conclusion
PD-ECGF/TP is expressed in lung adenocarcinoma and squamous cell carcinoma cell lines, but not in small cell carcinoma cell lines.
Supporting Evidence
- None of the small-cell lung carcinoma cell lines demonstrated expression of PD-ECGF/TP mRNA.
- Four of six non-small cell carcinoma cell lines expressed the PD-ECGF/TP transcript.
- The cell lines derived from squamous cell carcinoma and adenocarcinomas expressed PD-ECGF/TP mRNA and protein.
- Immunoblotting confirmed the presence of PD-ECGF/TP protein in certain lung carcinoma cell lines.
Takeaway
This study looked at how a specific protein is found in some types of lung cancer cells but not in others, which could help doctors tell the cancers apart.
Methodology
The study involved analyzing mRNA and protein expression of PD-ECGF/TP in various lung carcinoma cell lines using techniques like Northern blot analysis and immunoblotting.
Want to read the original?
Access the complete publication on the publisher's website